However, consistent with its distribution pattern during normal B cell development, FCRL1 expression appears to be lower in cases of acute lymphoblastic leukemia (ALL), which derives from bone marrow B cell precursors (115), and multiple myeloma that originates from transformed plasma cells (116). The gene discussed is FCRL1; the disease is acute lymphoblastic leukemia.